ZFIN Image: Alhashem et al., 2022, Fig. 4-supplement 1

Image

Figure Caption

Fig. 4-supplement 1

Somites and neural tissue formation are not altered by Notch inhibition.

(A, B) cb1045 in situ hybridisation upon (A) control (DMSO, n = 23) and (B) DAPT (n = 30) treatment. Arrows indicate segmentation defects. (C, D) myod in situ hybridisation upon (C) control (DMSO, n = 47) and (D) DAPT (n = 45) treatment. (E, F) dld (deltaD) in situ hybridisation upon (E) control (DMSO, n = 25) and (F) DAPT (n = 30) treatment. (G, H) Antibody staining for heavy myosin (F59) upon (G) control (DMSO, n = 37) and (H) DAPT (n = 32) treatment. (I, J) Antibody staining for Znp1 upon (I) control (DMSO, n = 35) and (J) DAPT (n = 42) treatment. (K, L) Antibody staining for acetylated tubulin (Ac Tub) upon (K) control (DMSO, n = 20) and (L) DAPT (n = 27) treatment. Arrowheads indicate the level at which trunk neural crest (TNC) migration was analysed. Anterior to the left, dorsal top.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Elife